Dr. Melissa A Chu, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1420 Hwy 62 65 N, Harrison, AR 72601 Phone: 870-741-3600 Fax: 870-741-6800 |
Stephen R. Maes, M.D. Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 825 N Spring St, Suite F, Harrison, AR 72601 Phone: 870-741-8800 Fax: 870-741-4545 |
Cherisse Melissa Baldeo, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 114 E Crandall Ave, Harrison, AR 72601 Phone: 870-741-6065 |
Dr. Thomas Brent Rosson Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 724 N Spring St, Harrison, AR 72601 Phone: 870-743-2448 Fax: 870-741-2449 |
Dr. Ronald Angelo Rubin Rubio, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 123 Claude Parrish Ave., Harrison, AR 72601 Phone: 870-365-2550 Fax: 870-743-2008 |
Candice Baldeo, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 620 N Main St, Harrison, AR 72601 Phone: 870-414-4244 Fax: 870-414-4943 |
Steven M Shrum, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 N Main St, Harrison, AR 72601 Phone: 870-743-4900 Fax: 870-743-4949 |
Ronald E Revard, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 702 N. Spring Street, Harrison, AR 72601 Phone: 870-365-0761 Fax: 870-365-0763 |
Finnbogi O Karlsson, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 815 N Main St, Harrison, AR 72601 Phone: 870-688-5533 Fax: 870-436-2603 |
News Archive
New research out of Wake Forest University School of Medicine identifies the presence of cardiovascular risk factors as an indicator of how likely it is that elderly, hospitalized patients who receive intravenous immunoglobulin (IVIg) treatment will have a stroke or heart attack.
Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts. The test may eventually help some patients avoid needless surgery to remove the harmless variety.
The latest news and discoveries in medicine, physics, environmental science, and interdisciplinary fields will be featured at the 56th Annual Meeting of the Biophysical Society (BPS), held Feb. 25 - Feb. 29, 2012, at the San Diego Convention Center in San Diego, Calif. With more than 4,000 poster presentations, 200 exhibits, 20 symposia, and 6,000 research scientists in attendance each year, the BPS Annual Meeting is the largest meeting of biophysicists in the world.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
› Verified 6 days ago